TORONTO, May 28, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today issued a Letter to Shareholders from the Company's Board of Directors (the "Letter"). The Letter is a response to the amended and restated dissident proxy circular filed by Apollo on May 20, 2025, and in particular Apollo's plan for the Company. The full text of the Letter to Shareholders follows. MESSAGE FROM THE MEDIPHARM BOA ...

Core Insights - Vireo Growth Inc. has successfully completed the acquisition of WholesomeCo Cannabis and the Arches proprietary technology platform, enhancing its profitability and competitive position in the market [1][3] - The total consideration for the acquisitions amounted to $69.8 million, paid in 134.2 million Subordinate Voting Shares at a reference price of $0.52 per share [2] - The acquisition of Wholesome is based on a multiple of 4.175x the projected 2024 "Reference EBITDA" of $16 million, with performance milestones set for December 31, 2026 [2] Financial Details - The purchase price for Wholesome represents a multiple of 4.175x the expected EBITDA, indicating a strategic valuation approach [2] - Shareholders involved in the transaction have agreed to voluntary share lock-up provisions, with shares unlocking over a 33-month period [2] Strategic Implications - The acquisitions are expected to bolster Vireo's profitability profile and create competitive advantages through the proprietary technology and analytics platform [3] - The company anticipates that other pending merger transactions will also close in the second quarter of 2025, indicating ongoing growth and expansion efforts [3]

Core Viewpoint - Dogecoin Cash, Inc. has finalized its stock dividend distribution, with a payment date set for May 9, 2025, and the record date remaining November 25, 2024, with no changes to the amount or terms of the dividend [1][3][4]. Group 1: Dividend Details - The stock dividend consists of a new class of preferred stock, where shareholders will receive one share of unrestricted preferred stock for every 1,000 shares of common stock held as of the record date [4]. - The preferred stock, designated as Series A Preferred, allows holders to receive one share of common stock annually per preferred share, contingent upon declaration by the Board of Directors [5]. - The preferred stock is not convertible but can be redeemed at the company's discretion at a rate of ten shares of common stock for each preferred share before October 25, 2034 [5]. Group 2: Company Overview - Dogecoin Cash, Inc. operates in the blockchain innovation sector and owns PrestoDoctor, a leader in medical cannabis telemedicine [7]. - The company holds a patented cannabis strain and a patented cannabis lozenge for hypertension treatment, and is involved in cannabis product development and licensing [7]. - Dogecoin Cash, Inc. is leveraging emerging digital assets and decentralized finance solutions to enhance its offerings and create new market opportunities [7].

MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its first fiscal quarter ended March 31, 2025 on Friday, May 9, 2025 before the market opens. Vireo Growth management will host a conference call with the investment community that same day, Friday, May 9, 2025 at 8:30 a.m. ET (7:30 a.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1- ...

Company Overview - Dogecoin Cash, Inc. has finalized its corporate name change, which is now reflected across U.S. stock market systems following notification from FINRA [1] - The name change was authorized through a Certificate of Amendment filed with the Nevada Secretary of State on November 13, 2024, and became market effective on April 25, 2025 [2] - The trading symbol (CBDS) remains unchanged at this time [3] Business Operations - Dogecoin Cash, Inc. operates PrestoDoctor, a leader in medical cannabis telemedicine [4] - The company holds the first patented cannabis strain, Ecuadorian Sativa aka "CTA", and a patented cannabis lozenge for hypertension treatment [4] - Dogecoin Cash, Inc. is engaged in cannabis product development, licensing, and blockchain innovation, leveraging emerging digital assets and decentralized finance (DeFi) solutions [4]

Core Insights - Aurora Cannabis Inc. is participating as a leader in the inaugural Global Cannabis Regulatory Summit (GCRS) in Washington, D.C. on March 26-27, 2025, highlighting its role in advocating for policy reform in the cannabis industry [1][2] Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [3] - The company offers a diverse portfolio of adult-use brands including Drift, San Rafael '71, Daily Special, Tasty's, Being, and Greybeard, as well as medical cannabis brands such as MedReleaf, CanniMed, Aurora, and Whistler Medical Marijuana Co. [3] - Aurora also holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [3] Industry Engagement - The GCRS will facilitate discussions among regulators, members of Congress, international policy experts, and cannabis industry executives to shape the future of the global cannabis industry [2][3] - Aurora's participation in panel discussions aims to enhance understanding of the distinctions between medical and adult-use cannabis, informed by international political and regulatory consensus [3]

Core Viewpoint - Real estate investment trusts (REITs) are popular among income-seeking investors due to their requirement to distribute most earnings as dividends, but they face challenges that can threaten dividend payouts [1] Group 1: Innovative Industrial Properties (IIP) - IIP focuses on the medical cannabis industry by purchasing real estate from marijuana growers and leasing it back to them [2] - The cannabis industry has faced difficulties, impacting IIP's operations, including declining revenue and earnings, and a significant tenant, PharmaCann, defaulting on rent obligations, which accounted for about 17% of IIP's rental revenue [4] - A deal was reached with PharmaCann for repayment of owed rent and a new lease agreement, while IIP continues to own 109 properties across 19 states, with medical cannabis legal in 38 states [5] - IIP has maintained its dividend despite recent challenges, appealing to investors looking for resilient dividend options [6] Group 2: Medical Properties Trust (MPT) - MPT operates medical facilities and has faced issues with two tenants declaring bankruptcy, leading to financial difficulties and reduced payouts [7] - MPT has begun addressing these challenges by securing new tenants for facilities previously occupied by Steward Health Care, with average lease terms of about 18 years [8] - MPT has 396 medical properties across the U.S. and Europe, and despite recent challenges, it is expected to benefit from long-term trends in the healthcare sector, such as an aging population [9] Group 3: Investment Comparison - IIP generates higher funds from operations and has a significantly higher annual dividend per share and trailing-12-month dividend yield compared to MPT [11] - MPT operates in the medical industry, which has strong long-term prospects, while the future of the cannabis sector remains uncertain [12] - The uncertainty surrounding the cannabis industry raises questions about IIP's future performance, while MPT is expected to gradually return to stable financial results and increase dividends [13] - The choice between IIP and MPT depends on investor preferences, with bullish investors on cannabis favoring IIP and risk-averse investors opting for MPT [14]

________________________ Akanda Corp. As filed with the Securities and Exchange Commission on February 20, 2024 Registration No. 333-_______ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 (Exact name of Registrant as specified in its charter) ________________________ | | | (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identificat ...

As filed with the Securities and Exchange Commission on [ ], 2023. Registration No. 333-274606 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 2 to FORM S-1 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Utah 8049 84-3829824 (I.R.S. Employer Identification No.) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 5097 South 900 East Suite 100 Salt Lake City, UT 84117 KINDLY MD, INC. (Exact name ...